Chittorgarh.com Logo
Loading...

Gland Pharma IPO Details

IPO Open Nov 9, 2020
IPO Close Nov 11, 2020
IPO Price ₹1500
Face Value ₹1
IPO Size ₹6,479.55 Cr
Listing At BSE, NSE
Lot Size 10
Open an Instant Account with Zerodha
  1. Mankind Pharma files papers for $700 million plus IPO; Largest ever in sector

    Sep 16, 2022 2:23:00 PM

    Gland Pharma was the previous record holder which launched an $869 million IPO in November 2020. The company’s IPO comprises an offer for the sale of 4,00,58,884 equity shares by selling ...

    Publish by : The Financial Express
  2. Mankind Pharma files for IPO, could be second largest among pharma firms

    Sep 16, 2022 4:29:00 PM

    The fourth largest pharmaceutical company in the domestic market, Mankind Pharma, filed its draft red herring prospectus (DRHP) papers with the Securities and Exchange Board of India (Sebi) on Friday ...

    Publish by : Business Standard
  3. MC Exclusive | Mankind Pharma files papers for $700 million plus IPO

    Sep 16, 2022 3:30:00 PM

    The current record in the sector is held by Gland Pharma which launched an $869 million IPO in November 2020. Mankind Pharma is India’s fourth largest pharmaceutical company in terms of ...

    Publish by : MSN
  4. Mankind Pharma, Maker Of Manforce Condoms, Files For IPO

    Sep 16, 2022 12:34:00 PM

    This will be one of the largest public issues by a domestic drug manufacturer after the Rs 6,480-crore IPO of Gland Pharma in 2020.

    Publish by : Outlookindia
  5. Manforce Condom manufacturer Mankind’s IPO set to be one of the biggest in the pharma sector

    Sep 16, 2022 2:30:00 PM

    The record for the largest IPO in the pharma space is currently held by Gland Pharma with its $869 million public offering back in 2020. The cash rich Mankind has completed the e-filing of its ...

    Publish by : The Free Press Journal
  6. How the IPO Bubble Burst, and Where Do We Go from Here?

    Sep 17, 2022 5:24:00 PM

    In the last few months, there has been a repeating theme in the headlines that mention “IPO drought.” According to Renaissance Capital, the number of U.S. IPOs is down 80% this year versus the ...

    Publish by : Nasdaq
  7. Melt Pharmaceuticals Begins U.S. IPO Process

    Sep 27, 2022 10:56:00 AM

    Melt Pharma is a clinical stage biopharma developing candidates for sedation and acute pain that has filed for a U.S. IPO. Click here to read my take on MELT.

    Publish by : Seeking Alpha
  8. Ankit Doshi

    Sep 4, 2022 9:01:00 AM

    The initial public offering of drugmaker Gland Pharma Ltd saw lukewarm interest with the IPO nearing... The initial public offering of drugmaker Gland Pharma Ltd got off to a slow start on the first ...

    Publish by : VCCircle
  9. Mankind Pharma files for IPO, could be one of largest ever in pharma

    Sep 16, 2022 12:36:00 PM

    Mankind Pharma has filed its draft red herring prospectus (DRHP) papers with market regulator Securities and Exchange Board of India (SEBI) to raise funds through initial public offering (IPO).

    Publish by : Mint

Gland Pharma IPO Alerts

1. Gland Pharma IPO Listing Date & Info  Thursday, November 19, 2020 8:34:13 PM

The IPO Shares of Gland Pharma Limited IPO are proposed to list on Friday, November 20, 2020 at BSE, NSE. The public issue of Gland Pharma IPO was opened on Nov 9, 2020 and closed for subscription on Nov 11, 2020. Gland Pharma IPO Listing Date and Information:

Gland Pharma Limited Listing Date

Listing DateFriday, November 20, 2020
BSE Script Code543245
NSE SymbolGLAND
Listing In
ISININE068V01023
Issue Price[.]
Face ValueRs 1 Per Equity Share

2. Gland Pharma IPO Allotment Status  Tuesday, November 17, 2020 10:37:43 AM

The allotment status of Gland Pharma Limited IPO is now available online. The public issue of Gland Pharma IPO was open on Nov 9, 2020 and closed for subscription on Nov 11, 2020. The equity shares of the company to be list at BSE, NSE.

3. Gland Pharma IPO Opens on Nov 9, 2020  Tuesday, November 3, 2020 9:10:55 PM

Gland Pharma Limited is entering in the capital market with an IPO of [.] Equity Shares of Rs 1 aggregating up to Rs [.] Crore. The price for the issue has been set at Rs 1490 - Rs 1500 Per Equity Share.

Gland Pharma Ltd, the Hyderabad-based company is one of the fastest-growing generic injectable companies. It manufactures a diversified range of high-quality complex injectables. The company offers products like sterile injectables, oncology, and ophthalmics, complex injectables (peptides, suspensions, hormonal products, long-acting injectables), NCE-1s, First-to-File products, etc.

The issue opens on Nov 9, 2020 and closes for subscription on Nov 11, 2020. The equity shares of the company to be list at BSE, NSE.

4. Gland Pharma IPO Closes on Nov 11, 2020  Tuesday, November 3, 2020 9:10:55 PM

The issue of Gland Pharma Limited opens on Nov 9, 2020 and closes for subscription on Nov 11, 2020. The equity shares of the company to be list at BSE, NSE. The price for the issue has been set at Rs 1490 - Rs 1500 Per Equity Share.

Gland Pharma IPO News & Events FAQs

The Gland Pharma IPO is proposed to open on Nov 9, 2020. The IPO application ends on Nov 11, 2020.

Retail investors can apply in the retail or non-institutional investor category from Nov 9, 2020 to Nov 11, 2020. The Gland Pharma IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

The Gland Pharma IPO will open for subscription on Nov 9, 2020. The public issue will close on Nov 11, 2020.